Card Id
|
Type Of Strain
|
Strain Name
|
Internal Code
|
Gene Symbol
|
Gene Name
|
Disease
|
Stock Type
|
Submitter
|
Developer
|
imsr
|
|
Targeted mutant.
|
129.Cg-Atp1a2tm1Kwk
|
tmCKwk
|
Atp1a2
|
ATPase, Na+/K+ transporting, alpha 2 polypeptide
|
Anatomy Dermatology Metabolism Neurobiology Physiology
|
|
KAWAKAMI KIYOSHI
|
Kiyoshi Kawakami(Jichi Medical University)
|
|
|
Targeted mutant.
|
129.Cg-Atp1a2tm2Kwk
|
tmNKwk
|
Atp1a2
|
ATPase, Na+/K+ transporting, alpha 2 polypeptide
|
Anatomy Dermatology Metabolism Neurobiology Physiology
|
|
KAWAKAMI KIYOSHI
|
Kiyoshi Kawakami(Jichi Medical University)
|
|
|
Targeted mutant.
|
B6-Mir142tm1Card
|
21-KBW111reKO17
|
Mir142
|
microRNA 142
|
Dermatology Development Hematology Immunology
|
|
Masatake ARAKI
|
|
|
|
Targeted mutant.
|
B6-Rpt3tm1
|
floxed Rpt3
|
Psmc4
|
proteasome (prosome, macropain) 26S subunit, ATPase, 4
|
Aging Behavior Cell biology Dentistry Dermatology Development Diabetes Digestive Disorders Endocrine Disorders Genetics Hematology Immunology Laboratory-animal Science Metabolism Molecular biology Neurobiology Obesity Ophthalomology Osteosis Otorhinology Reproduction Respiratory System Urology cancer infectious peromelia
|
|
Takahashi Ryosuke
|
Yoshitaka Tashiro , Ryousuke Takahashi(Department of Neurology kyoto University Graduate School of Medicine)
|
|
|
Targeted mutant.
|
B6-Aco1em1Card
|
Aco1-Del23
|
Aco1
|
aconitase 1
|
Dermatology Laboratory-animal Science Molecular biology
|
|
Masatake ARAKI
|
Masatake Araki(IRDA, Kumamoto University)
|
|
|
Targeted mutant.
|
B6-Aco1em2Card
|
Aco1-Del26
|
Aco1
|
aconitase 1
|
Dermatology Laboratory-animal Science Molecular biology
|
|
Masatake ARAKI
|
Masatake Araki(IRDA, Kumamoto University)
|
|
|
Targeted mutant.
|
B6-Aco1em3Card
|
Aco1-SNP12
|
Aco1
|
aconitase 1
|
Dermatology Laboratory-animal Science Molecular biology
|
|
Masatake ARAKI
|
Masatake Araki(IRDA, Kumamoto University)
|
|
|
Targeted mutant.
|
B6-Aco1em4Card
|
Aco1-SNP16
|
Aco1
|
aconitase 1
|
Dermatology Laboratory-animal Science Molecular biology
|
|
Masatake ARAKI
|
Masatake Araki(IRDA, Kumamoto University)
|
|
|
Targeted mutant.
|
B6-Aco1em5Card
|
Aco1-SNP18
|
Aco1
|
aconitase 1
|
Dermatology Laboratory-animal Science Molecular biology
|
|
Masatake ARAKI
|
Masatake Araki(IRDA, Kumamoto University)
|
|
|
Transgenic.
|
B6-Tg(Tyr-CRE/ERT2)Lru
|
Tyr-CRE-ERT2
|
Cre/ERT2
|
Cre recombinase, Estrogen receptor
|
Aging Cell biology Dermatology Development Laboratory-animal Science Molecular biology Ophthalomology Otorhinology cancer
|
|
Kato Masashi
|
Lionel Larue(Institut Curie)
|
|
|
Targeted mutant.
|
B6.129-Atp1a2tm2Kwk
|
BL6N
|
Atp1a2
|
ATPase, Na+/K+ transporting, alpha 2 polypeptide
|
Anatomy Dermatology Metabolism Neurobiology Physiology
|
|
KAWAKAMI KIYOSHI
|
Kiyoshi Kawakami(Jichi Medical University)
|
|
|
Targeted mutant.
|
B6.129-Chrm1tm1
|
1NJ B6.129-Chrm1tm1
|
Chrm1
|
cholinergic receptor, muscarinic 1, CNS
|
Anatomy Dermatology Development Immunology Metabolism Neurobiology Physiology cancer
|
|
Unknown Unknown
|
MATSUI Minoru(Graduate Sch. Pharm, Sci., Univ.Tokyo)
|
|
|
Targeted mutant.
|
B6.129-Chrm2tm1
|
2NJ B6.129-Chrm2tm1
|
Chrm2
|
cholinergic receptor, muscarinic 2, cardiac
|
Anatomy Dermatology Development Immunology Metabolism Neurobiology Physiology cancer
|
|
Unknown Unknown
|
MATSUI Minoru(Graduate Sch. Pharm. Sci., Univ. Tokyo)
|
Released publicly
|
|
Targeted mutant.
|
B6.129-Chrm3tm1
|
3NJ B6.129-Chrm3tm1
|
Chrm3
|
cholinergic receptor, muscarinic 3, cardia
|
Anatomy Dermatology Development Immunology Metabolism Neurobiology Physiology cancer
|
|
Unknown Unknown
|
MATSUI Minoru(Graduate Sch. Pharm. Sci., Univ. Tokyo)
|
Released publicly
|
|
Targeted mutant.
|
B6.129-Chrm4tm1
|
4NJ B6.129-Chrm4tm1
|
Chm4
|
cholinergic receptor, muscarinic 4
|
Anatomy Dermatology Development Immunology Metabolism Neurobiology Physiology cancer
|
|
Unknown Unknown
|
MATSUI Minoru(Graduate Sch.Pharm. Sci., Univ. Tokyo)
|
Released publicly
|
|
Targeted mutant.
|
B6.129-Chrm5tm1
|
5NJ B6.129-Chrm5tm1
|
Chrm5
|
cholinergic receptor, muscarinic 5
|
Anatomy Dermatology Development Immunology Metabolism Neurobiology Physiology cancer
|
|
Unknown Unknown
|
MATSUI Minoru(東京大学薬学部)
|
Released publicly
|
|
Targeted mutant.
|
B6.129-Ptger2tm1Sna
|
EP2KO
|
Ptger2
|
prostaglandin E receptor 2 (subtype EP2)
|
Dermatology Development Immunology Neurobiology Physiology cancer
|
|
Narumiya Shuh
|
Shuh Narumiya(Kyoto University Graduate School of Medicine, Department of pharmacology)
|
|
|
Targeted mutant.
|
B6.129-S1pr2tm1Jch
|
SIP2-Knockout
|
S1pr2 (Synonym: Edg5)
|
Endothelial differentiation, sphingolipid G-protein-coupled receptor,5
|
Dermatology Development Immunology Metabolism Neurobiology Physiology
|
|
ISHII ISAO
|
Isao Ishii(Showa Pharmaceutical University) Dr. Jerold Chun(The Scripps Research Institute)
|
|
|
Targeted mutant.
|
B6.129X1-DSg3tm1Stan
|
C57BL/6-[Ko]Dsg3 N11 B6.129X1-Dsg3tm1Stan N11
|
Dsg3
|
desmoglein 3
|
Dermatology Development
|
|
Shigeo Koyasu
|
John R. Stanley(University of Pennsylvania)
|
|
|
Transgenic.
|
B6.Cg-Tg(CAG-cre)CZ-MO2Osb
|
(CAG-cre)
|
Cre
|
Cre recombinase
|
Anatomy Dermatology Development Immunology Neurobiology Physiology cancer
|
|
Masaru Okabe
|
Masaru Okabe(Research Institute for Microbial Diseases, Osaka University)
|
|
|
Transgenic.
|
B6.Cg-Tg(CAG-floxed Neo-EGFP)REP08Osb
|
REP-08
|
EGFP
|
green fluorescent protein
|
Anatomy Dermatology Development Immunology Neurobiology Physiology cancer
|
|
Masaru Okabe
|
Masaru Okabe(Research Institute for Microbial Diseases, Osaka University)
|
|
|
Transgenic.
|
B6.D2-Tg(CAG-floxed Neo-DT)03Osb
|
REP-DT
|
DT
|
Diphtheria toxin gene subunit A
|
Anatomy Dermatology Development Immunology Neurobiology Physiology cancer
|
|
Masaru Okabe
|
Masaru Okabe(Research Institute for Microbial Diseases, Osaka University)
|
|
|
Targeted mutant.
|
B6;129-Chrm1tm1 Chrm2tm1 Chrm4tm1
|
M1M2M4KO
|
Chrm1 Chrm2 Chrm4
|
cholinergic receptor, muscarinic 1, CNS cholinergic receptor, muscarinic 2 cholinergic receptor, muscarinic 4
|
Anatomy Dermatology Development Immunology Metabolism Neurobiology Physiology cancer
|
|
Unknown Unknown
|
MATSUI Minoru(Graduate Sch. Pharm. Sci., Univ. Tokyo)
|
|
|
Targeted mutant.
|
B6;129-Chrm1tm1 Chrm3tm1 Chrm5tm1
|
M1M3M5KO
|
Chrm1 Chrm3 Chrm5
|
cholinergic receptor, muscarinic 1, CNS cholinergic receptor, muscarinic 3, cardiac cholinergic receptor, muscarinic 5
|
Anatomy Dermatology Development Immunology Metabolism Neurobiology Physiology cancer
|
|
Unknown Unknown
|
MATSUI, Minoru(Graduate Sch. Pharm. Sci., Univ. Tokyo)
|
|
|
Targeted mutant.
|
B6;129-Chrm1tm1 Chrm3tm1
|
M1M3KO
|
Chrm1 Chrm3
|
cholinergic receptor, muscarinic 1, CNS cholinergic receptor, muscarinic 3, cardiac
|
Anatomy Dermatology Development Immunology Metabolism Neurobiology Physiology cancer
|
|
Unknown Unknown
|
MATSUI, Minoru(Graduate Sch. Pharm. Sci., Univ. Tokyo)
|
|
|
Targeted mutant.
|
B6;129-Chrm2tm1 Chrm4tm1
|
M2M4KO, C57BL/6J, 2x4
|
Chrm2 Chrm4
|
cholinergic receptor, muscarinic 2, cardiac cholinergic receptor, muscarinic 4
|
Anatomy Dermatology Development Immunology Metabolism Neurobiology Physiology cancer
|
|
Unknown Unknown
|
MATSUI, Minoru(Graduate Sch. Pharm. Sci., Univ. Tokyo)
|
|
|
Targeted mutant.
|
B6;129-Chrm2tm1 Chrm5tm1
|
2x5
|
Chrm2 Chrm5
|
cholinergic receptor, muscarinic 2, cardiac cholinergic receptor, muscarinic 5
|
Anatomy Dermatology Development Immunology Metabolism Neurobiology Physiology cancer
|
|
Unknown Unknown
|
MATSUI, Minoru
|
|
|
Targeted mutant.
|
B6;129-Chrm3tm1 Chrm4tm1
|
3x4
|
Chrm3 Chrm4
|
cholinergic receptor, muscarinic 3, cardiac cholinergic receptor, muscarinic 4
|
Anatomy Dermatology Development Immunology Metabolism Neurobiology Physiology cancer
|
|
Unknown Unknown
|
MATSUI, Minoru(Graduate Sch. Pharm. Sci., Univ. Tokyo)
|
|
|
Targeted mutant.
|
B6;129-Chrm3tm1 Chrm5tm1
|
3x5
|
Chrm3 Chrm5
|
cholinergic receptor, muscarinic 3, cardiac cholinergic receptor, muscarinic 5
|
Anatomy Dermatology Development Immunology Metabolism Neurobiology Physiology cancer
|
|
Unknown Unknown
|
MATSUI, Minoru(Graduate Sch. Pharm. Sci., Univ. Tokyo)
|
|
|
Targeted mutant.
|
B6;129-Chrm4tm1 Chrm5tm1
|
M4M5KO, C57BL/6J, 4x5
|
Chrm4 Chrm5
|
cholinergic receptor, muscarinic 4 cholinergic receptor, muscarinic 5
|
Anatomy Dermatology Development Immunology Metabolism Neurobiology Physiology cancer
|
|
Unknown Unknown
|
MATSUI, Minoru(Graduate Sch. pharm. Sci., Univ. Tokyo)
|
|
|
Targeted mutant. Transgenic.
|
B6;129-Ednrbtm1Ywa Tg(DBH-Ednrb)Ywa
|
ENRB•Tg B6;129-Ednrbtm1Ywa Tg(DBH-Ednrb)Ywa
|
Ednrb Ednrb
|
endothelin receptor type B endothelin receptor type B
|
Dermatology cancer
|
|
Kato Masashi
|
The University of Texas(Yanagisawa Masashi)
|
|
|
Targeted mutant.
|
B6;129-Ptger4tm1Sna
|
EP4KO
|
Ptger4
|
prostaglandin E receptor 4
|
Dermatology Development Immunology Metabolism Neurobiology Physiology cancer
|
|
Narumiya Shuh
|
Shu Narumiya(Kyoto University Graduate School of Medicine, Medical Innovation Center)
|
|
|
Targeted mutant.
|
B6;129Sv-Ednrbtm1
|
Ednrb-floxed
|
Ednrb
|
endothelin receptor type B
|
Dermatology Development Metabolism Physiology cancer
|
|
Kato Masashi
|
Jeffery W. Walker(University of Wisconsin)
|
|
|
Transgenic.
|
B6;C-Tg(Mt1-RET)192Num
|
B6;C-Tg(Mt1-RFP/RET)192Num
|
Ret
|
Ret proto-oncogene (multiple endocrine neoplasia and medullary thyroid carcinoma 1, Hirschsprung disease)(Human)
|
Dermatology cancer
|
|
Kato Masashi
|
Masashi Kato(Nagoya University Graduate School of Medicine)
|
Released publicly
|
|
Transgenic.
|
B6;C-Tg(Mt1-RET)242Num
|
B6;C-Tg(Mt1-RFP/RET)242Num
|
Ret
|
Ret proto-oncogene (multiple endocrine neoplasia and medullary thyroid carcinoma 1, Hirschsprung disease)(Human)
|
Dermatology cancer
|
|
Kato Masashi
|
Masashi Kato(Nagoya University Graduate School of Medicine)
|
Released publicly
|
|
Transgenic.
|
B6;C-Tg(Mt1-RET)304Num
|
B6;C-Tg(Mt1-RFP/RET)304Num
|
Ret
|
Ret proto-oncogene (multiple endocrine neoplasia and medullary thyroid carcinoma 1, Hirschsprung disease)(Human)
|
Dermatology cancer
|
|
Kato Masashi
|
Masashi Kato(Nagoya University Graduate School of Medicine)
|
Released publicly
|
|
Transgenic.
|
B6;C3-Tg(Actb-EGFP)CX-FM139Osb
|
F139 B6C3F1B6C3F1-TgN(act-EGFP)OsbCX-FM139 B6;C3-Tg(Actb-EGFP)CX-FM139Osb
|
EGFP
|
enhanced green fluorescent protein (Jelly fish)
|
Anatomy Dermatology Development Immunology Neurobiology Physiology cancer
|
|
Masaru Okabe
|
MASARU OKABE(Genome Information Research Center Osaka University)
|
Released publicly
|
|
Transgenic.
|
B6;C3-Tg(acro3-EGFP)01Osb
|
GS-001
|
EGFP
|
green fluorescent protein
|
Anatomy Dermatology Development Immunology Neurobiology Physiology cancer
|
|
Masaru Okabe
|
Masaru Okabe(Research Institute for Microbial Diseases, Osaka University)
|
|
|
Spontaneous/Chemical induced mutant.
|
B6;CB- pocyCard
|
B6;CB-pocy/Card
|
pocy
|
familial polycythemia
|
Dermatology Genetics Hematology Laboratory-animal Science
|
|
Masatake ARAKI
|
Masatake Araki(IRDA, Kumamoto University)
|
|
|
Targeted mutant.
|
B6;CB-Ttrtm2(IRES-hTTR)Imeg
|
TtrIRES-hTTR
|
Ttr
|
transthyretin
|
Anatomy Dermatology Metabolism Neurobiology
|
|
Ken-ichi YAMAMURA
|
Li Zhenghua (Division of Developmental Genetics, IMEG )
|
|
|
Targeted mutant.
|
B6;CB-Ttrtm2(IRES-hTTR-puro(-))Imeg
|
TtrIRES-hTTR-puro(-)
|
Ttr
|
transthyretin
|
Anatomy Dermatology Metabolism Neurobiology
|
|
Ken-ichi YAMAMURA
|
Li Zhenghua (Division of Developmental Genetics, IMEG )
|
|
|
Targeted mutant.
|
B6;CB-Ttrtm2(hTTR)Imeg
|
TtrhTTR/hTTR
|
Ttr
|
transthyretin
|
Anatomy Dermatology Metabolism Neurobiology
|
|
Ken-ichi YAMAMURA
|
Li Zhenghua (Division of Developmental Genetics, IMEG )
|
|
|
Targeted mutant.
|
B6;CB-Ttrtm2(hTTRV30M)Imeg
|
TtrhV30M/hV30M
|
Ttr
|
transthyretin
|
Anatomy Dermatology Metabolism Neurobiology
|
|
Ken-ichi YAMAMURA
|
Li Zhenghua (Division of Developmental Genetics, IMEG )
|
|
|
Targeted mutant.
|
B6;CB-Ttrtm2Imeg
|
Ttr-/-
|
Ttr
|
transthyretin
|
Anatomy Dermatology Metabolism Neurobiology
|
|
Ken-ichi YAMAMURA
|
Li Zhenghua (Division of Developmental Genetics, IMEG )
|
|
|
Targeted mutant.
|
B6;CB-Ttrtm2Imeg
|
TtrhTTR-puro(-)
|
Ttr
|
transthyretin
|
Anatomy Dermatology Metabolism Neurobiology
|
|
Ken-ichi YAMAMURA
|
Li Zhenghua (Division of Developmental Genetics, IMEG )
|
|
|
Targeted mutant.
|
B6;CB-Dtrtm1(lox)
|
loxHB-2
|
Dtr(synonym:Hegf1)
|
diphtheria toxin receptor
|
Anatomy Dermatology Development Physiology cancer
|
|
Unknown Unknown
|
Eisuke Mekada(Research Institute for Microbial Diseases, Osaka Univ.)
|
Released publicly
|
|
Targeted mutant.
|
B6;CB-Dtrtm2(lox)
|
loxHB-2
|
Dtr(synonym:Hegf1)
|
diphtheria toxin receptor
|
Anatomy Dermatology Development Physiology cancer
|
|
Unknown Unknown
|
Eisuke Mekada(Research Institute for Microbial Diseases, Osaka Univ.)
|
Released publicly
|
|
Spontaneous/Chemical induced mutant.
|
B6;CB-pocy2/Card
|
pocy2
|
pocy
|
familial polycythemia
|
Dermatology Genetics Hematology Laboratory-animal Science
|
|
Masatake ARAKI
|
Masatake Araki(IRDA, Kumamoto University)
|
|
|
Spontaneous/Chemical induced mutant.
|
B6;CB-pocy3/Card
|
pocy3
|
pocy
|
familial polycythemia
|
Dermatology Genetics Hematology Laboratory-animal Science
|
|
Masatake ARAKI
|
Masatake Araki(IRDA, Kumamoto University)
|
|
|
Targeted mutant.
|
B6;CBA-Xpatm1Ktl
|
Xpa knockout mouse
|
Xpa
|
xeroderma pigmentosum, complementation group A
|
Dermatology Immunology cancer
|
|
- -
|
Kiyoji Tanaka(Lab. of Organismal Biosystems, Graduate School of Frontier Biosciences,Osaka University)
|
|